DNA immunization of mice against SIVmac239 gag and env using Rev- independent expression plasmids

AIDS Research and Human Retroviruses

Volumn 14, Issue 1, 1998, Pages 83-90

  Indraccolo, Stefano ^a,b   Feroli, Fiorella ^b   Minuzzo, Sonia ^b   Mion, Marta ^b   Rosato, Antonio ^b   Zamarchi, Rita ^b   Titti, Fausto ^c   Verani, Paola ^c   Amadori, Alberto ^b,d   Chieco Bianchi, Luigi ^b  

^a IST Biotechnology Section   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d Department of Oncology and Surgical Sciences ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAG PROTEIN; REV PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MESSENGER RNA SYNTHESIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RETROVIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURAL GENE;

EID: 0031974904     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.83     Document Type: Article

References (33)

1. Luciw P: Human immunodeficiency viruses and their replication. In: Virology (Fields BN, ed.). Lippincott-Raven, Philadelphia, Pennsylvania, 1995, pp. 1881-1952.
2. Gardner MB, Endres M, and Barry P: The simian retroviruses. In: The Retroviridae (Levy JA, ed.) Plenum Press, New York, 1994, pp. 133-276.
3. Zolotukhin AS, Valentin A, Pavlakis GN, and Felber BK: Continuous propagation of RRE(-) and Rev(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral lymphocytes. J Virol 1994;68:7944-7952.
4. Bray M, Prasad S, Dubay JW, Hunter E, Jeang KT, Rekosh D, and Hammarskjöld ML: A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci USA 1994;91:1256-1260.
5. Kestler HW III, Kodama T, Ringler D, Marthas M, Pedersen N, Ratner A, Regier D, Sehgal T, Daniel M, King N, and Desrosier RC: Induction of AIDS by molecularly cloned virus. Science 1990;248:1109-1112.
6. Regier DA and Desrosier RC: The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retroviruses 1990;6:1221-1231.
7. Benko DM, Robinson R, Solomin L, Mellini M, Felber BK, and Pavlakis GN: Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting Rev-responsive element does not affect the fate of viral mRNA. New Biol 1990;2:1111-11222.
8. Tabernero C, Zolotukhin AS, Valentin A, Pavlakis GN, and Felber BK: The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function. J Virol 1996;70:5998-6011.
9. Sambrook J, Fritsch EF, and Maniatis T: Introduction of recombinant vectors into mammalian cells. In: Molecular Cloning: A Laboratory Manual (Irwin N, ed.), 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989, pp. 16.32-16.36.
10. Schwartz S, Felber BK, Benko DM, Fenyö E-M, and Pavlakis GN: Cloning and functional analysis of multiply spliced mRNa species of human immunodeficiency virus type 1. J Virol 1990;64: 2519-2529.
11. + cells. J Virol 1997;71:3341-3345.
12. Indraccolo S, Mion M, Biagiotti R, Romagnani S, Morfini M, Longo G, Zamarchi R, Chieco-Bianchi L, and Amadori A: Genetic variability of the human CD4 V2 domain. Immunogenetics 1996;44:70-72.
13. Zamarchi R, Veronese ML, Titti F, Geraci A, Verani P, Rossi GB, Amadori A, and Chieco-Bianchi L: In vitro spontaneous production of anti-simian immunodeficiency virus (SIV) antibodies is a reliable tool in the follow-up of protection of SIV-vaccinated monkeys. Aids Res Hum Retroviruses 1993;9:1139-1144.
14. Schwartz S, Campbell M, Nasioulas G, Harrison J, Felber BK, and Pavlakis GN: Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J Virol 1992;66:7176-7182.
15. Reddy TR, Kraus G, Suhasini M, Leavitt MC, and Wong-Staal F: Identification and mapping of inhibitory sequences in the human immunodeficiency virus type 2 vif gene. J Virol 1995;69: 5167-5170.
16. Le SY, Malim MH, Cullen BR, and Maizel JV: A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. Nucleic Acids Res 1990;18: 1613-1623.
17. Endres CL, Bergquam EP, Axthelm MK, and Wong SW: Suppression of simian immunodeficiency virus replication by human immunodeficiency virus type 1 trans-dominant negative Rev mutants. J Virol 1995;69:5164-5166.
18. Pomerantz RJ, Seshamma T, and Trono D: Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: Potential implications for therapy. J Virol 1992;66: 1809-1813.
19. Winslow BJ and Trono D: The blocks to human immunodeficiency virus type 1 tat and rev functions in mouse cell lines are independent. J Virol 1993;67:2349-2354.
20. Rizvi TA, Schmidt RD, Lew KA, and Keeling ME: Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay. Virology 1996;222:457-463.
21. Tang H, Gaietta GM, Fischer WH, Ellisman MH, and Wong-Staal F: A Cellular cofactor for the constitutive transport element of type D retrovirus. Science 1997;276:1412-1415.
22. Wagener S, Norley S, Zur Megede J, Kurth R, and Cichutek K: Induction of antibodies against SIV antigens after intramuscular nucleic acid inoculation using complex expression constructs. J Biotechnol 1996;44:59-65.
23. McKnight A, Clapham PR, and Weiss RA: HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: Restrictions to replication at distinct stages. Virology 1994;201:8-18.
24. Wieder KJ, Chatis P, Boltax J, Wieder I, Nuovo G, and Strom TB: Human immunodeficiency virus type 1 entry into murine cell lines and lymphocytes from transgenic mice expressing a glycoprotein 120-binding mutant mouse CD4. AIDS Res Hum Retroviruses 1996;12:867-876.
25. Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, and Weiner DB: Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993;90: 4156-4160.
26. Wang B, Boyer J, Srikantan V, Coney L, Carrano R, Phan C, Merva M, Dang K, Agadjanan M, Gilbert L, Ugen KE, Williams WV, and Weiner DB: DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol 1993;12:799-805.
27. Cheng SM, Blume M, Lee SG, Hung PP, Hirsch VM, and Johnson PR: Coexpression of biologically active simian immunodeficiency virus (SIV) Rev and Env in an SV40 system: The SIV rev gene regulates env expression. Virology 1990;177:816-819.
28. Schwartz S, Felber BK, and Pavlakis GN: Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol 1992;66:150-159.
29. + lymphoid cells. Gene Ther 1998; in press.
30. Donnelly JJ, Ulmer JB, Shiver JW, and Liu MA: DNA vaccines. Annu Rev Immunol 1997;15:617-648.
31. Okuda K, Bukawa H, Hamajima K, Kawamoto S, Sekigawa K, Yamada Y, Tanaka S, Ishi N, Aoki I, and Nakamura M: Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res Hum Retroviruses 1995;11:933-943.
32. Boyer JD, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney L, and Weiner DB: Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med 1997;3:526-532.
33. Yasutomi Y, Robinson HL, Lu S, Mustafa F, Lekutis C, Arthos J, Mullins JI, Voss G, Manson K, Wyand M, and Letvin NL: Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol 1996;70:678-681.